ABMED · GLOBAL REGULATORY & MARKET ACCESS

Asia-Pacific and Eurasian markets

38 international markets (countries and regional markets) in our service materials; each jurisdiction has its own requirements.

Find your target market

HSA

Singapore

Market access overview

HSA uses risk classes A–D. Class A product-registration exemption is distinct from SHARE product notification and dealer licensing; other devices use the applicable evaluation route.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

MDA

Malaysia

Market access overview

MDA registration, the local authorised representative, establishment licensing and applicable CAB conformity assessment are separate requirements. Determine class A–D and the eligible pathway.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Thai FDA

Thailand

Market access overview

Confirm the Thai FDA risk class, listing, notification or licensing route, local importer qualification and the applicable ASEAN dossier and Thai-language labelling.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Ministry of Health · Medical devices

Vietnam

Market access overview

Assess A/B declarations and C/D circulation registration separately under the applicable Vietnamese rules and transition arrangements. Use local classification and Vietnamese information.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

FDA Philippines

Philippines

Market access overview

Confirm the local establishment LTO and the applicable CMDN, CMDR or exemption route for the risk class and implementation stage. Maintain the authorised product scope.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Kemenkes

Indonesia

Market access overview

Assess class A–D, product grouping, a qualified local entity and the applicable circulation authorisation. Prepare technical evidence and Indonesian-language labelling.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

CDSCO

India

Market access overview

Under the Medical Devices Rules 2017, an authorised Indian agent normally applies on MD-14 for an MD-15 import licence. Assess specific exemptions and class A–D requirements individually.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

DRAP

Pakistan

Market access overview

DRAP distinguishes class A enlistment from class B–D registration. Establishment licensing, manufacturer authorisation and import responsibility must also be assessed.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Ministry of Health / NDDA

Kazakhstan

Market access overview

Kazakhstan is geographically in Central Asia and is also an EAEU member. Distinguish national registration from the EAEU route, territorial coverage and current transition conditions.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Ministry of Health / national review authority

Uzbekistan

Market access overview

Confirm Uzbekistan’s applicable national registration procedure, local authorised responsibility, technical evidence and any testing. An EAEU certificate does not automatically replace Uzbek registration.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Roszdravnadzor

Russia

Market access overview

Distinguish the Russian national and EAEU routes, intended sales territory and current transition arrangements. Assess Russian evidence, testing and applicable QMS inspections.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Ministry of Health / EAEU authorities

Belarus

Market access overview

Distinguish Belarusian national registration from the EAEU route. Confirm representative responsibility, the certificate territory, evidence and current transition conditions.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

MFDS / designated bodies

South Korea

Market access overview

MFDS uses classes I–IV with notification, certification or approval as applicable. Confirm the importer’s licence, the technical-review route and applicable KGMP evidence individually.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

PMDA / MHLW

Japan

Market access overview

Confirm JMDN, class and the notification, third-party certification or approval route under the PMD Act. Assess the Japanese MAH/D-MAH, foreign-manufacturer registration and QMS responsibilities.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

TFDA

Taiwan

Market access overview

Assess TFDA class I/II/III, the applicable listing or registration route, local medical-device dealer and manufacturing-site QSD requirements. Mainland-origin imports require separate trade-scope checks.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Department of Health · MDD

Hong Kong

Market access overview

Confirm the applicable MDACS voluntary listing route and Hong Kong Local Responsible Person. Do not present proposed statutory regulation as if all devices already require mandatory registration.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Medsafe

New Zealand

Market access overview

WAND is a notification database, not a product approval. Assess device scope and exemptions, the actual New Zealand Sponsor and the applicable notification and maintenance duties.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

TGA

Australia

Market access overview

Assess device or IVD classification, exemptions and the applicable ARTG inclusion route. Australian Sponsor responsibility, manufacturer conformity evidence and application audit are separate matters.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Based on the regulatory section of ABMED’s 38-market report, with source material dated 17 November 2026. Confirm current rules and the specific product before implementation. Market coverage does not imply a company office in every market.